NCT03109860

Brief Summary

The study investigates the effect of an open (in full view of the patient) vs hidden treatment (without the patient's knowledge).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 12, 2017

Completed
Last Updated

November 14, 2017

Status Verified

April 1, 2017

Enrollment Period

1.8 years

First QC Date

April 5, 2017

Last Update Submit

November 10, 2017

Conditions

Keywords

Chronic neuropathic pain

Outcome Measures

Primary Outcomes (1)

  • Mechanical visual analogue scale

    Neuropathic pain assessed on mechanical visual analogue scale

    10 minutes after treatment administration

Interventions

Open-hiddenBEHAVIORAL

Administration of a treatment openly (in full view of the patient) vs hidden (without the patient's knowledge).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with chronic neuropathic pain after thoracic surgery.

You may qualify if:

  • \- Neuropathic pain \> 3 on a 0-10 NRS.

You may not qualify if:

  • Psychiatric or competing neurological disorders.
  • Known allergies to any medications, including local anesthetics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2017

First Posted

April 12, 2017

Study Start

April 17, 2015

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

November 14, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share